Fantauzzi, Alessandra <br/><br/>
Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimization.  [electronic resource] 

 -  The new microbiologica  Oct 2015 
 - 531-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1121-7138 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>CD4 Lymphocyte Count<br/>Cytokines--immunology<br/>Dideoxynucleosides--administration & dosage<br/>Drug Combinations<br/>Drug Substitution<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Lamivudine--administration & dosage<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Treatment Outcome<br/>Viral Load--drug effects